Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Snowflake Inc. director Frank Slootman sold 7,874 shares on March 17, 2026, for roughly $1.38 million under a trading plan adopted in September 2025. The company reported robust product revenue growth and a sizable increase in remaining performance obligations, while analysts adjusted price targets and ratings following quarterly results.
Benoit Dageville, Snowflake Inc. founder and chief architect, completed share sales totaling roughly $336,477 on March 17, 2026, and surrendered additional shares on March 16, 2026 to meet tax liabilities. The transactions were carried out under a 10b5-1 trading plan adopted March 28, 2025. The company continues to show solid revenue growth and pro…
Elvia Cowan, senior vice president of finance and chief accounting officer at Vaxcyte, Inc. (NASDAQ: PCVX), sold 1,892 shares of common stock on March 17, 2026, for roughly $105,146 under a Rule 10b5-1 plan. The trades occurred in two blocks at weighted-average prices of $55.387 and $56.263. After the sales Cowan directly holds 28,975 shares. The c…
Uber Technologies SVP and Chief People Officer Nikki Krishnamurthy sold 30,000 shares of common stock on March 16, 2026 for roughly $2.23 million and completed additional share disposals to satisfy tax obligations. On the same day she exercised options to acquire 76,000 shares tied to the vesting of restricted stock units. The transactions occurred…
James R. Potts, Executive Vice President, General Counsel and Secretary of Barrett Business Services Inc (NASDAQ: BBSI), sold 1,803 shares on March 17, 2026, at $28.68 per share for a total of $51,710. The transaction was carried out under a Rule 10b5-1 trading arrangement, executed by an attorney-in-fact. The company reported modest year-over-year…
George Herrera, a director at Travel & Leisure Co. (TNL), sold 2,962 shares of common stock in two transactions on March 17 and 18, 2026, generating about $208,464 in proceeds. The transactions leave Herrera with 1,853 directly held shares and 46,333 deferred stock units. Separately, Wyndham Hotels & Resorts raised its quarterly dividend, named a p…
WEX Inc. Chief Accounting Officer Jennifer Kimball carried out an automatic sale of 715 shares on March 17, 2026, under a Rule 10b5-1 trading plan, realizing $112,841. The same filing records the vesting of restricted stock units and market share units, tax-related dispositions, and Kimball's post-transaction holdings. The moves come as WEX shares …
Globalharvest Holdings Venture Ltd., a roughly 10% owner of Mission Produce, Inc. (NASDAQ: AVO), purchased 3,695 shares at a weighted average price of $11.94 on March 17, 2026. The acquisition raises its direct stake to 9,991,577 shares as the stock has dipped following a fiscal Q1 earnings and revenue shortfall.
George W. Brochick, a director at Universal Technical Institute, sold 5,000 shares on March 17, 2026, generating roughly $182,938. The transaction occurred while UTI shares traded close to their 52-week high of $38.02 and following a fiscal first-quarter report that beat revenue expectations but slightly missed on earnings per share. Truist Securit…
Marie Mendoza, senior vice president and general counsel at Kratos Defense & Security Solutions, sold 1,518 shares on March 16, 2026, for $134,882 under a previously established 10b5-1 plan. The report also details recent defense industry developments involving Kratos and Rocket Lab, including contracts, program milestones and a $1.17 billion equit…
Blackstone Mortgage Trust Chief Financial Officer Marcin Urbaszek sold 452 shares on March 17, 2026, for $19.13 a share, netting $8,646. The transaction was made under a Rule 10b5-1 plan adopted in March 2025 to cover tax obligations tied to vested restricted stock. The firm reported Q4 2025 GAAP net income of $0.24 per share, noted a reduction in …
Lisa Bodensteiner, Senior Vice President, Chief Legal Officer and Corporate Secretary of Synaptics Inc. (NASDAQ: SYNA), sold 334 shares under a pre-established 10b5-1 plan and had 782 shares withheld to meet tax obligations tied to RSU settlement. After the transactions, she directly holds 71,191 shares. Synaptics reported fiscal second-quarter 202…
Maria Cervantes de Burgreen, vice president and corporate controller at Kratos Defense & Security Solutions (NASDAQ: KTOS), sold 6,270 shares on March 16, 2026 under a 10b5-1 trading plan, raising $559,844. The transactions occurred at prices between $87.3625 and $90.454. After the sale she directly holds 59,369 shares. Separately, Rocket Lab secur…
Adaptive Biotechnologies President and COO Julie Rubinstein sold 57,180 shares under a 10b5-1 plan between March 16 and March 18, 2026, raising $762,209. At the same time she exercised options to acquire 44,166 shares at $6.55 per share for $289,287. After the transactions Rubinstein holds 494,920 shares. The insider activity coincides with the com…
Meta Platforms Chief Operating Officer Javier Olivan sold 1,555 shares of Class A common stock on March 16, 2026, generating proceeds of $982,791 at $632.02 per share. The transaction was completed under a Rule 10b5-1 trading plan adopted November 17, 2025, and included both direct and indirect dispositions through family entities and trusts. The s…
Phillip D. Carrai, president of Kratos Defense & Security Solutions' STC Division, sold 6,500 shares on March 16, 2026, under a pre-arranged 10b5-1 plan for roughly $578,947. The company continues to secure defense contracts and expand programs even as some analysts flag valuation concerns and the firm moves forward with a large equity offering.
Meta Platforms director Robert M. Kimmitt sold 580 Class A shares on March 16, 2026, realizing $366,571 at $632.02 per share. The sale was carried out under a Rule 10b5-1 trading plan adopted August 15, 2025. At the time of reporting, Meta shares were trading at $615.68, roughly 23% below their 52-week high of $796.25, while the company retains a m…
Williams-Sonoma President and CEO Laura Alber sold 19,990 shares on March 16, 2026, for about $3.6 million under a Rule 10b5-1 plan. The transaction was reported on a Form 4; Alber continues to hold a large direct stake and additional indirect holdings. The company posted a fourth-quarter earnings-per-share beat but missed revenue expectations, whi…
MediaAlpha CEO Steven Yi sold 4,000 shares of Class A common stock on March 18, 2026, under a Rule 10b5-1 plan to cover taxes tied to vesting restricted stock units. The company reported Q4 2025 revenue of $291 million, a small miss versus the $295.02 million expected, while maintaining record financial results attributed to strategic initiatives. …
Jamie L. Reynoso, chief executive of Medicare Advantage at Clover Health Investments Corp. (CLOV), sold 5,833 Class A shares on March 18, 2026, for roughly $11,141 under a previously established Rule 10b5-1 trading plan. The firm also reported fourth-quarter 2025 revenue above expectations and disclosed a technical integration with CMS Aligned Netw…
SkyWater Technology CFO Steve Manko sold 91,109 shares on March 16, 2026, realizing roughly $2.5 million in proceeds from transactions priced between $27.54 and $28.10. He also exercised options for 9,708 shares at a $10.14 exercise price. The activity follows a 237% one-year gain for the stock and comes amid IonQ's planned $1.8 billion acquisition…
Rhonda Farnum, Senior Vice President of Communications and Medical Affairs at Theravance Biopharma, sold 31,067 ordinary shares on March 16, 2026, netting roughly $433,637. The trades were carried out under a 10b5-1 plan and leave Farnum with 232,699 shares. The insider activity comes amid the company’s decision to discontinue the ampreloxetine pro…
Prologis director Sarah A. Slusser sold 111 shares of the REIT's common stock across transactions between July 10, 2025 and January 28, 2026, generating about $12,631. The trades occurred at prices between $108.58 and $127.57. Slusser had previously purchased 13 shares on May 14, 2025 at $107.34 and now directly holds 11 Prologis shares. The compan…
Peter Richard Orszag, Lazard Inc.'s chief executive officer and chairman, sold 69,170 Lazard shares on March 17, 2026, realizing roughly $2.8 million. The transactions were made under a Rule 10b5-1 trading plan adopted in March 2025 and are reported to cover estimated taxes and other personal expenses. Separately, Orszag carried out additional shar…
Kratos Defense & Security Solutions director Scott I. Anderson sold 15,000 shares on March 16, 2026, netting $1.33 million in five transactions executed under a 10b5-1 plan adopted September 10, 2025. The sales come amid a near 198% year-over-year share price rise, recent defense contracts and partnerships, and a $1.17 billion equity offering that …
